2nd Quarter - Report

SMITH GARSON for SYMRISE INC

Period 2nd Quarter 2020 Filed Jul 13, 2020 Signed by Amy R. Williams

Official filing
Firm
SMITH GARSON
Client
SYMRISE INC
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA regulatory issues

LobbyistCovered position, as disclosed
BRETT GARSON —

Contacted: SENATE; Food & Drug Administration (FDA)

Tariff (miscellaneous tariff bills) TAR

Tariff exclusion process

LobbyistCovered position, as disclosed
CATHERINE BEAL New —
BRETT GARSON —

Contacted: Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.